Home > Boards > US Listed > Medical - Drugs >

Arbutus Biopharma Corporation (ABUS)

Add ABUS Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board:
Last Post: 2/7/2016 9:55:14 AM - Followers: 103 - Board type: Free - Posts Today: 0

Arbutus Biopharma Corporation







Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201


As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.




Important Company Highlights: 

LNP Delivery Platform

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.





Recent News:





Links of importance for those that trade Canadian stocks:




 CNW Group Newswire:

Canadian Insider:

Currency Converter:


Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

Share Structure:   See filings

Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 Currency Converter:


 8-34-200/ 6 MOS ppo, accum.,R.S.I., PPS, vol 

daily retracement % 
18 mos, black, daily, retrace 3%, pos retrace 5%, retrace 7%, volume, candles, pps, 






 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ABUS News: Arbutus Biopharma to Participate in Upcoming Investor Conferences 02/04/2016 04:30:00 PM
ABUS News: Kuros Biosurgery Holding Ltd. Closes Merger With Cytos Biotechnology Ltd. Which is Renamed Kuros Biosciences Ltd. 01/20/2016 01:00:00 AM
ABUS News: Kuros Biosurgery Holding Ltd. Closes Merger With Cytos Biotechnology Ltd. Which is Renamed Kuros Biosciences Ltd. 01/20/2016 01:00:00 AM
ABUS News: Current Report Filing (8-k) 01/11/2016 06:09:26 AM
ABUS News: Statement of Changes in Beneficial Ownership (4) 12/22/2015 06:01:49 PM
#4953  Sticky Note NEW COMPANY NAME/ ARBUTUS BIOPHARMA CORPORATION/ $ABUS recent news/filings[/b mick 08/06/15 01:42:07 PM
#5013   ABUS News: Arbutus Biopharma to Participate in Upcoming mick 02/07/16 09:55:14 AM
#5012   Arbutus Biopharma Co (ABUS) mick 02/07/16 09:55:08 AM
#5011   Who is working on a Zika vaccine? piecesofeight 02/01/16 11:03:08 AM
#5010   Just keeps dropping like it doesn't ever want rivervalley 01/28/16 01:55:17 PM
#5009   ABUS/ daily retracement % mick 01/20/16 02:52:59 PM
#5008,plamda mick 01/20/16 12:16:52 PM
#5007   DAILY/ mick 01/16/16 12:33:48 PM
#5006   Arbutus Biopharma Co (ABUS) mick 12/31/15 10:24:32 AM
#5005 mick 12/19/15 01:50:06 PM
#5004   while many others in this sector on my rivervalley 12/09/15 02:18:52 PM
#5003   made yet another buy of ABUS this afternoon. rivervalley 12/04/15 04:42:15 PM
#5002   Arbutus Biopharma Co (ABUS) mick 11/22/15 05:27:50 PM
#5001 mick 11/15/15 01:37:01 PM
#5000   Lets see if next week brings in the Tdash 11/13/15 01:59:00 PM
#4999 mick 11/07/15 01:29:11 PM
#4998   couldn't resist averaging down a little more this rivervalley 10/23/15 10:33:29 AM
#4997   Hard to believe this couldn't push through the rivervalley 10/22/15 01:43:01 PM
#4996 mick 10/20/15 08:02:40 AM
#4995   great way to end the week with another rivervalley 10/16/15 06:36:32 PM
#4994   a nice green day finally, and hopefully more rivervalley 10/15/15 10:45:16 PM
#4993 mick 10/13/15 03:58:20 PM
#4992   is ABUS finally ready to start a move rivervalley 10/09/15 10:08:17 AM
#4991   That would require knowledge and review beyond my nanopatent 10/08/15 10:48:13 PM
#4990   Nano patent Are there any impingements on TKMR patents? Echo 20 Echo20 10/08/15 05:24:04 PM
#4989   Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization nanopatent 10/08/15 05:07:20 PM
#4988   Nano patent The previous post sounds familiar. Echo 20 Echo20 10/08/15 03:13:55 PM
#4987   Nano patent The cure for aging gave you cancer. But Echo20 10/08/15 02:45:03 PM
#4986   Nano patent I just read a report that found Echo20 10/08/15 01:47:08 PM
#4985   Results of Search in US Patent Collection db for: nanopatent 10/08/15 01:16:42 PM
#4984   Nano patent I just read a report that found Echo20 10/08/15 01:07:22 PM
#4983 mick 10/05/15 02:02:25 AM
#4982   IBB up over 4% currently this morning, and rivervalley 09/30/15 10:13:10 AM
#4981 mick 09/26/15 03:54:14 PM
#4980   good deal, one I have in this sector rivervalley 09/24/15 02:32:42 PM
#4979   Did anything come from that $140 million DoD nanopatent 09/21/15 06:34:53 PM
#4978   Most look like increased government funding on some KarinCA 09/21/15 04:31:33 PM
#4977   Form CT ORDER - Confidential treatment order filed 21sept15 KarinCA 09/21/15 03:54:45 PM
#4976   HOD 7.72, finally making a move back up rivervalley 09/17/15 03:14:07 PM
#4975   7.35 HOD so far this morning. Its a start. rivervalley 09/17/15 09:52:04 AM
#4974 mick 09/14/15 02:10:49 PM
#4973   Arbutus Biopharma Co (ABUS) mick 09/12/15 04:47:59 PM
#4972   added some shares today and dropped my ave rivervalley 09/10/15 03:15:26 PM
#4971   vol seems to be tapering off the last rivervalley 09/10/15 03:03:00 PM
#4970   well for me anyways its more than just rivervalley 09/09/15 02:49:27 PM
#4969   i have not bought this dip yet/ something mick 09/09/15 11:43:29 AM
#4968   so I take it you never bought in? rivervalley 09/09/15 09:16:17 AM
#4967   since merger nothing but downtrend. links ????? mick 09/04/15 10:48:07 AM
#4966   are you in? out? I see some links rivervalley 09/03/15 09:31:59 PM
#4965 mick 09/02/15 08:09:09 PM
#4964 mick 08/25/15 01:03:51 PM